Your session is about to expire
← Back to Search
Healthy Diet for High Cholesterol (FH-Diet Trial)
N/A
Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Postmenopausal women (without hormone replacement)
Premenopausal women with a regular menstrual cycle for >3 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up appetite sensation was measured at the end of the first (day 7) and the last week (day 28) of each diet. changes between day 28 and day 7 will be calculated and compared between diet.
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the effects of a healthy diet on cholesterol levels and the metabolome in people with HeFH. The investigators will also study how a healthy diet affects cardiovascular disease risk in this population.
Who is the study for?
This trial is for adults with a genetic condition called HeFH, which leads to high cholesterol. It's open to premenopausal women with regular menstrual cycles and postmenopausal women not on hormone therapy. People over 60, those with heart disease or severe obesity, uncontrolled blood pressure, diabetes, or allergies to the diet components can't join.
What is being tested?
The study compares two diets: the standard North American diet (NAD) and one based on Canada's Food Guide (CFG), which is low in red meat and high in plants. The goal is to see how these diets affect bad cholesterol levels and identify markers that show if someone's following a healthy diet.
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include digestive adjustments as your body adapts to new foods from either the NAD or CFG diets.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a postmenopausal woman not on hormone replacement.
Select...
I am a premenopausal woman with regular periods for over 3 months.
Select...
I have been diagnosed with familial hypercholesterolemia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ appetite sensation was measured at the end of the first (day 7) and the last week (day 28) of each diet. changes between day 28 and day 7 will be calculated and compared between diet.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~appetite sensation was measured at the end of the first (day 7) and the last week (day 28) of each diet. changes between day 28 and day 7 will be calculated and compared between diet.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Post-diet differences in LDL-C levels.
Secondary study objectives
Post-diet differences in 10-year risk of atherosclerotic cardiovascular disease
Post-diet differences in C-reactive protein levels.
Post-diet differences in other atherogenic lipoproteins and lipids
+2 moreOther study objectives
Association between the plasma metabolomic signature of the healthy CFG diet and LDL-C levels
Post-diet differences in appetite sensation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Standard North American diet (NAD diet)Experimental Treatment1 Intervention
During 28 days, participants will receive de NAD diet. The NAD diet reflects current dietary intakes of the French-Canadian adult population in terms of foods, nutrients, and diet quality, as characterized in recent surveys conducted in an age- and a sex-representative sample of adults from the Province of Quebec. Intakes of minimally processed fruits and vegetables will be low; animal proteins, mostly red and processed meats, will be consumed more often than vegetable proteins; grains will be mostly refined; and ready-to-eat/ready-to-heat foods and sugary beverages will be served daily.
Group II: Canada's Food Guide principles (CFG diet)Experimental Treatment1 Intervention
During 28 days, participants will receive de CFG diet. The CFG diet emphasizes low intakes of red and processed meats and high intakes of minimally processed plant foods with water as the drink of choice, as per Canada's Food Guide. The number of portions of protein foods, whole-grains, fruits and vegetables to be served daily reflects the recommended ¼-¼-½ proportions. Regarding protein quality, vegetable proteins are served more often than animal proteins as stated in Canada's Food Guide. Weekly, red meat is served once, two days are meatless, and one day is free of animal products.
Find a Location
Who is running the clinical trial?
Laval UniversityLead Sponsor
434 Previous Clinical Trials
178,588 Total Patients Enrolled
Université de MontréalOTHER
221 Previous Clinical Trials
104,242 Total Patients Enrolled
Centre de Recheche du Centre Hospitalier Université LavalOTHER
4 Previous Clinical Trials
1,887 Total Patients Enrolled
Jean-Philippe Drouin-ChartierStudy DirectorLaval University
1 Previous Clinical Trials
258 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with familial hypercholesterolemia.I am a postmenopausal woman not on hormone replacement.I have conditions that increase my risk of heart disease, such as being over 60, diabetes, severe obesity, or high blood pressure.You are allergic to any of the ingredients in the experimental diets.I am a premenopausal woman with regular periods for over 3 months.
Research Study Groups:
This trial has the following groups:- Group 1: Standard North American diet (NAD diet)
- Group 2: Canada's Food Guide principles (CFG diet)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.